JAMA Network Home
Sign In
Perspective

New Molecules and Indications for GLP-1 Medicines

JAMA 10.1001/jama.2025.14392

September 15, 2025 at 11:00 AM EDT

Read the full article

This Perspective explores recent progress and future directions in glucagon-like peptide-1 medicines.

Corresponding Author: Daniel J. Drucker, MD, Mount Sinai Hospital, 600 University Ave, Mailbox 39, Toronto, ON M5G1X5, Canada (drucker@lunenfeld.ca).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2025.14392?utm_source=for_the_media&utm_medium=referral&utm_campaign=ftm_links&utm_term=091525

Copy to clipboard

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.

Editor's Picks